83 related articles for article (PubMed ID: 14717585)
1. Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods.
Khayat R; Batra R; Bebernitz GA; Olson MW; Tong L
Biochemistry; 2004 Jan; 43(2):316-22. PubMed ID: 14717585
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease.
Batra R; Khayat R; Tong L
Nat Struct Biol; 2001 Sep; 8(9):810-7. PubMed ID: 11524687
[TBL] [Abstract][Full Text] [Related]
3. Activity in monomers of human cytomegalovirus protease.
Holwerda B
Biochem Biophys Res Commun; 1999 Jun; 259(2):370-3. PubMed ID: 10362516
[TBL] [Abstract][Full Text] [Related]
4. Dimerization of the human cytomegalovirus protease: kinetic and biochemical characterization of the catalytic homodimer.
Margosiak SA; Vanderpool DL; Sisson W; Pinko C; Kan CC
Biochemistry; 1996 Apr; 35(16):5300-7. PubMed ID: 8611517
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the induced-fit mechanism and catalytic activity of the human cytomegalovirus protease homodimer via molecular dynamics simulations.
de Oliveira CA; Guimarães CR; Barreiro G; de Alencastro RB
Proteins; 2003 Sep; 52(4):483-91. PubMed ID: 12910449
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutagenesis probing the catalytic role of arginines 165 and 166 of human cytomegalovirus protease.
Liang PH; Brun KA; Feild JA; O'Donnell K; Doyle ML; Green SM; Baker AE; Blackburn MN; Abdel-Meguid SS
Biochemistry; 1998 Apr; 37(17):5923-9. PubMed ID: 9558326
[TBL] [Abstract][Full Text] [Related]
7. Active human cytomegalovirus protease is a dimer.
Darke PL; Cole JL; Waxman L; Hall DL; Sardana MK; Kuo LC
J Biol Chem; 1996 Mar; 271(13):7445-9. PubMed ID: 8631772
[TBL] [Abstract][Full Text] [Related]
8. Structural and biochemical studies of inhibitor binding to human cytomegalovirus protease.
Khayat R; Batra R; Qian C; Halmos T; Bailey M; Tong L
Biochemistry; 2003 Feb; 42(4):885-91. PubMed ID: 12549906
[TBL] [Abstract][Full Text] [Related]
9. A double mutation at the tip of the dimer interface loop of triosephosphate isomerase generates active monomers with reduced stability.
Schliebs W; Thanki N; Jaenicke R; Wierenga RK
Biochemistry; 1997 Aug; 36(32):9655-62. PubMed ID: 9245397
[TBL] [Abstract][Full Text] [Related]
10. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease.
Tong L; Qian C; Massariol MJ; Bonneau PR; Cordingley MG; Lagacé L
Nature; 1996 Sep; 383(6597):272-5. PubMed ID: 8805706
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of human cytomegalovirus protease.
Shieh HS; Kurumbail RG; Stevens AM; Stegeman RA; Sturman EJ; Pak JY; Wittwer AJ; Palmier MO; Wiegand RC; Holwerda BC; Stallings WC
Nature; 1996 Sep; 383(6597):279-82. PubMed ID: 8805708
[TBL] [Abstract][Full Text] [Related]
12. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
[TBL] [Abstract][Full Text] [Related]
14. Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease.
Khayat R; Batra R; Massariol MJ; Lagacé L; Tong L
Biochemistry; 2001 May; 40(21):6344-51. PubMed ID: 11371196
[TBL] [Abstract][Full Text] [Related]
15. Unique fold and active site in cytomegalovirus protease.
Qiu X; Culp JS; DiLella AG; Hellmig B; Hoog SS; Janson CA; Smith WW; Abdel-Meguid SS
Nature; 1996 Sep; 383(6597):275-9. PubMed ID: 8805707
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.
Tomasselli AG; Paddock DJ; Curry KA; Garlick RL; Leone JW; Lull JM; Mutchler VT; Baker CA; Cavey GS; Mathews WR; Shelly JA; Finzel BC; Baldwin ET; Wells PA; Tomich CS
Protein Expr Purif; 1998 Dec; 14(3):343-52. PubMed ID: 9882568
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human cytomegalovirus protease dimerization by analytical centrifugation.
Cole JL
Biochemistry; 1996 Dec; 35(48):15601-10. PubMed ID: 8952514
[TBL] [Abstract][Full Text] [Related]
18. Conformational change coupling the dimerization and activation of KSHV protease.
Pray TR; Reiling KK; Demirjian BG; Craik CS
Biochemistry; 2002 Feb; 41(5):1474-82. PubMed ID: 11814340
[TBL] [Abstract][Full Text] [Related]
19. Subunit interface residues of glutathione S-transferase A1-1 that are important in the monomer-dimer equilibrium.
Vargo MA; Nguyen L; Colman RF
Biochemistry; 2004 Mar; 43(12):3327-35. PubMed ID: 15035604
[TBL] [Abstract][Full Text] [Related]
20. Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad.
Chen P; Tsuge H; Almassy RJ; Gribskov CL; Katoh S; Vanderpool DL; Margosiak SA; Pinko C; Matthews DA; Kan CC
Cell; 1996 Sep; 86(5):835-43. PubMed ID: 8797829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
